ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

9 links0 made here, not in the record11 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03970382A Study of Gene EditedAutologous NeoantigenTargeted TCR T Cells Withor Without Anti-PD-1 inPatients With Solid TumorsPACT Pharma, Inc.Phase 1 · suspendedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSMelanomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termOvarian NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termProstatic NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termColorectal NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, Transitional CellThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termTriple Negative Breast Neop…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · BackgroundBackground · partnerInterleukin-2Entry “IL-2”, read by our name rule›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Nivolumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “nivolumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background · partner
Background · partner · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2NivolumabClaude Opus 5.5Background · partnerCurrent
Nov 2Interleukin-2Claude Opus 5.5BackgroundCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 14MelanomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Ovarian NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Prostatic NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Colorectal NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Transitional CellRule based · condition-kind ruleFinest filed termCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 14Triple Negative Breast NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 18NivolumabRule based · role ruleBackgroundAgrees
Nov 18Interleukin-2Rule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.